Intraoperative radiation therapy

Firsthand Technology Value Fund Discloses Revised Preliminary NAV of $3.75 Per Share as of March 31, 2023

Retrieved on: 
Wednesday, May 10, 2023
Professional Services, Finance, Intraoperative electron radiation therapy, Intraoperative radiation therapy, Bank statement, Cancer, ASX, NAV, CMP, Patient, Investment, Fund, Cryptocurrency, Security (finance)

Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its revised preliminary NAV, as of March 31, 2023, was $3.75.

Key Points: 
  • Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its revised preliminary NAV, as of March 31, 2023, was $3.75.
  • As of March 31, 2023, the Fund’s investment in IntraOp consisted of preferred stock plus debt securities and represented approximately 55.3% of the Fund’s preliminary net assets.
  • The Fund’s preliminary net assets as of March 31, 2023, include cash and cash equivalents of approximately $0.12 per share.
  • As of March 31, 2023, the Fund’s top five holdings constituted 132.2% of the Fund’s preliminary net assets, and 96.7% of our preliminary total investments.

Firsthand Technology Value Fund Discloses Preliminary NAV of $4.10 Per Share as of March 31, 2023

Retrieved on: 
Friday, May 5, 2023
Professional Services, Finance, Intraoperative electron radiation therapy, Intraoperative radiation therapy, Bank statement, Cancer, ASX, NAV, CMP, Patient, Investment, Fund, Cryptocurrency, Security (finance)

Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its preliminary NAV, as of March 31, 2023, was $4.10.

Key Points: 
  • Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its preliminary NAV, as of March 31, 2023, was $4.10.
  • As of March 31, 2023, the Fund’s investment in IntraOp consisted of preferred stock plus debt securities and represented approximately 50.7% of the Fund’s preliminary net assets.
  • The Fund’s preliminary net assets as of March 31, 2023, include cash and cash equivalents of approximately $0.12 per share.
  • As of March 31, 2023, the Fund’s top five holdings constituted 121.1% of the Fund’s preliminary net assets, and 96.7% of our preliminary total investments.

Firsthand Technology Value Fund Discloses Top Portfolio Holdings

Retrieved on: 
Thursday, April 6, 2023
Professional Services, Medical Devices, Technology, Environment, Semiconductor, Satellite, Green Technology, Engineering, Finance, Other Technology, Manufacturing, Health, Completeness, Intraoperative electron radiation therapy, Intraoperative radiation therapy, Bank statement, Cancer, ASX, CMP, Closed-end fund, Patient, Investment, Fund, Total, Cryptocurrency, Security (finance)

Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of February 28, 2023, were IntraOp Medical, Wrightspeed, Hera Systems, Revasum, and EQX Capital.

Key Points: 
  • Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of February 28, 2023, were IntraOp Medical, Wrightspeed, Hera Systems, Revasum, and EQX Capital.
  • As of February 28, 2023, the Fund’s investment in IntraOp consisted of preferred stock plus debt securities and represented approximately 39.3% of the Fund’s estimated total investments.
  • *
    The Fund also announced that as of February 28, 2023, the estimated total investments* of the Fund were approximately $42.5 million, or $6.32 per share, including cash and cash equivalents of approximately $0.15 per share.
  • As of that date, the Fund’s top five holdings constituted 96.6% of the Fund’s estimated total investments.

Firsthand Technology Value Fund Discloses Top Portfolio Holdings

Retrieved on: 
Tuesday, March 7, 2023
Professional Services, Green Technology, Environment, Finance, Fund, CMP, Closed-end fund, Bank statement, Intraoperative electron radiation therapy, Completeness, Patient, Cancer, ASX, Investment, Total, Intraoperative radiation therapy, Cryptocurrency, Security (finance)

Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of January 31, 2023, were IntraOp Medical, Wrightspeed, Hera Systems, Revasum, and EQX Capital.

Key Points: 
  • Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of January 31, 2023, were IntraOp Medical, Wrightspeed, Hera Systems, Revasum, and EQX Capital.
  • As of January 31, 2023, the Fund’s investment in IntraOp consisted of preferred stock plus debt securities and represented approximately 42.0% of the Fund’s estimated total investments.
  • *
    The Fund also announced that as of January 31, 2023, the estimated total investments* of the Fund were approximately $40.7 million, or $5.91 per share, including cash and cash equivalents of approximately $0.16 per share.
  • As of that date, the Fund’s top five holdings constituted 96.2% of the Fund’s estimated total investments.

Firsthand Technology Value Fund Discloses Preliminary NAV of $4.44 Per Share as of December 31, 2022

Retrieved on: 
Friday, February 3, 2023
Other Professional Services, Asset Management, Professional Services, Finance, Bank statement, Investment, Patient, Form 10-K, ASX, CMP, Intraoperative electron radiation therapy, Fund, Annual report, Intraoperative radiation therapy, NAV, Cancer, Cryptocurrency, Security (finance)

Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its preliminary NAV, as of December 31, 2022, was $4.44.

Key Points: 
  • Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its preliminary NAV, as of December 31, 2022, was $4.44.
  • As of December 31, 2022, the Fund’s investment in IntraOp consisted of preferred stock plus debt securities and represented approximately 55.9% of the Fund’s preliminary net assets.
  • The Fund’s preliminary net assets as of December 31, 2022, include cash and cash equivalents of approximately $0.10 per share.
  • As of December 31, 2022, the Fund’s top five holdings constituted 125.0% of the Fund’s preliminary net assets, and 95.4% of our preliminary total investments.

Firsthand Technology Value Fund Discloses Top Portfolio Holdings

Retrieved on: 
Thursday, December 15, 2022
Investment Company Act of 1940, Fund, Annual report, Intraoperative radiation therapy, SAN, ASX, Investment company, Intraoperative electron radiation therapy, Completeness, Total, Cancer, Form 10-K, Growth, Investment, Risk, Index fund, CMP, Patient, Renewable energy, Security (finance)

SAN JOSE, Calif., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of November 30, 2022, were IntraOp Medical, Wrightspeed, Hera Systems, Revasum, and EQX Capital.

Key Points: 
  • SAN JOSE, Calif., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of November 30, 2022, were IntraOp Medical, Wrightspeed, Hera Systems, Revasum, and EQX Capital.
  • Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund that invests in technology and cleantech companies.
  • More information about the Fund and its holdings can be found online at www.firsthandtvf.com .
  • Under normal circumstances, the Fund will invest at least 80% of its total assets for investment purposes in technology and cleantech companies.

Firsthand Technology Value Fund Discloses Top Portfolio Holdings

Retrieved on: 
Tuesday, November 22, 2022
Growth, SAN, Risk, ASX, Patient, Investment Company Act of 1940, Total, Investment, CMP, Annual report, Fund, Intraoperative radiation therapy, Cancer, Form 10-K, Completeness, Intraoperative electron radiation therapy, Index fund, Investment company, Renewable energy, Security (finance), Cryptocurrency

SAN JOSE, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the Fund), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of October 31, 2022, were IntraOp Medical, Wrightspeed, Hera Systems, Revasum, and EQX Capital.

Key Points: 
  • SAN JOSE, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the Fund), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of October 31, 2022, were IntraOp Medical, Wrightspeed, Hera Systems, Revasum, and EQX Capital.
  • Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund that invests in technology and cleantech companies.
  • More information about the Fund and its holdings can be found online at www.firsthandtvf.com .
  • Under normal circumstances, the Fund will invest at least 80% of its total assets for investment purposes in technology and cleantech companies.

Firsthand Technology Value Fund Discloses Preliminary NAV of $5.58 Per Share as of September 30, 2022

Retrieved on: 
Thursday, October 27, 2022
Investment Company Act of 1940, Mission statement, SEC, Intraoperative radiation therapy, NASDAQ, NAV, Private Securities Litigation Reform Act, Cancer, Growth, Forward-looking statement, Intraoperative electron radiation therapy, Risk, Fund, Patient, Technology, GLOBE, SAN, Investment, ASX, CMP, Solution, Renewable energy, Security (finance)

SAN JOSE, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the Fund), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its preliminary NAV, as of September 30, 2022, was $5.58.

Key Points: 
  • SAN JOSE, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the Fund), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its preliminary NAV, as of September 30, 2022, was $5.58.
  • As of September 30, 2022, the Funds investment in IntraOp consisted of preferred stock plus debt securities and represented approximately 54.0% of the Funds preliminary net assets.
  • The Funds preliminary net assets as of September 30, 2022, include cash and cash equivalents of approximately $0.17 per share.
  • Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund that invests in technology and cleantech companies.

Firsthand Technology Value Fund Discloses Top Portfolio Holdings

Retrieved on: 
Friday, September 23, 2022
Fund, ASX, Intraoperative radiation therapy, Risk, CMP, Investment Company Act of 1940, Growth, Private Securities Litigation Reform Act, Forward-looking statement, Patient, Investment, Cancer, Hedge fund, Total, Technology, Completeness, Solution, Board of directors, NASDAQ, Board, SAN, GLOBE, SEC, Investment company, Intraoperative electron radiation therapy, Mission statement, Security (finance), Cryptocurrency

SAN JOSE, Calif., Sept. 23, 2022 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the Fund), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of August 31, 2022, were IntraOp Medical, Wrightspeed, Hera Systems, Revasum, and EQX Capital.

Key Points: 
  • SAN JOSE, Calif., Sept. 23, 2022 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the Fund), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of August 31, 2022, were IntraOp Medical, Wrightspeed, Hera Systems, Revasum, and EQX Capital.
  • Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund that invests in technology and cleantech companies.
  • More information about the Fund and its holdings can be found online at www.firsthandtvf.com .
  • Under normal circumstances, the Fund will invest at least 80% of its total assets for investment purposes in technology and cleantech companies.

Firsthand Technology Value Fund Discloses Top Portfolio Holdings

Retrieved on: 
Monday, August 29, 2022
Completeness, Patient, Technology, Cancer, SAN, NASDAQ, Index fund, Solution, Investment Company Act of 1940, Total, Board, Fund, Investment company, CMP, SEC, Investment, GLOBE, Board of directors, ASX, Intraoperative radiation therapy, Risk, Intraoperative electron radiation therapy, Private Securities Litigation Reform Act, Growth, Mission statement, Forward-looking statement, Security (finance), Cryptocurrency

SAN JOSE, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the Fund), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of July 31, 2022, were IntraOp Medical, Wrightspeed, Revasum, Hera Systems, and EQX Capital.

Key Points: 
  • SAN JOSE, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the Fund), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of July 31, 2022, were IntraOp Medical, Wrightspeed, Revasum, Hera Systems, and EQX Capital.
  • Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund that invests in technology and cleantech companies.
  • More information about the Fund and its holdings can be found online at www.firsthandtvf.com .
  • Under normal circumstances, the Fund will invest at least 80% of its total assets for investment purposes in technology and cleantech companies.